First reported 13 hours ago -
Updated 13 hours ago -
WALTHAM, Mass., — Interleukin Genetics, Inc. (OTCQB: ILIU) today announced the introduction of PerioPredict™, the Company's new, next-generation version of the PST® genetic risk test for periodontal disease
. PerioPredict™ will be broadly available beginning ...
[Published Bay City Capital - 13 hours ago]